Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Semin Liver Dis

Retrieve available abstracts of 65 articles:
HTML format



Single Articles


    June 2022
  1. CHEW N, Ng CH, Truong E, Noureddin M, et al
    Non-Alcoholic Steatohepatitis Drug Development Pipeline: An Update.
    Semin Liver Dis. 2022 Jun 16. doi: 10.1055/a-1877-9656.
    PubMed     Abstract available


  2. KULKARNI AV, Premkumar M, Arab JP, Kumar K, et al
    EARLY DIAGNOSIS AND PREVENTION OF INFECTIONS IN CIRRHOSIS.
    Semin Liver Dis. 2022 Jun 7. doi: 10.1055/a-1869-7607.
    PubMed     Abstract available


    May 2022
  3. GRINSPAN LT, Villanueva A
    Biomarker Development Using Liquid Biopsy in Hepatocellular Carcinoma.
    Semin Liver Dis. 2022;42:188-201.
    PubMed     Abstract available


    February 2022
  4. GALLAHER CE, Shawcross DL
    Management of multidrug-resistant infections in cirrhosis.
    Semin Liver Dis. 2022 Feb 7. doi: 10.1055/a-1765-0056.
    PubMed     Abstract available


  5. PANDAY R, Monckton CP, Khetani SR
    The Role of Liver Zonation in Physiology, Regeneration, and Disease.
    Semin Liver Dis. 2022;42:1-16.
    PubMed     Abstract available


  6. CADAMURO M, Lasagni A, Sarcognato S, Guido M, et al
    The Neglected Role of Bile Duct Epithelial Cells in NASH.
    Semin Liver Dis. 2022;42:34-47.
    PubMed     Abstract available


  7. TERZI E, Ayuso C, Piscaglia F, Bruix J, et al
    Liver Imaging Reporting and Data System: Review of Pros and Cons.
    Semin Liver Dis. 2022;42:104-111.
    PubMed     Abstract available


    November 2021
  8. TELLEZ L, Rodriguez de Santiago E, Albillos A
    Fontan-Associated Liver Disease: Pathophysiology, Staging, and Management.
    Semin Liver Dis. 2021;41:538-550.
    PubMed     Abstract available


  9. RADUN R, Trauner M
    Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities.
    Semin Liver Dis. 2021;41:461-475.
    PubMed     Abstract available


  10. MAIWALL R, Sarin SK
    Plasma Exchange in Acute and Acute on Chronic Liver Failure.
    Semin Liver Dis. 2021;41:476-494.
    PubMed     Abstract available


  11. GU X, Lu Q, Zhang C, Tang Z, et al
    Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review.
    Semin Liver Dis. 2021;41:495-506.
    PubMed     Abstract available


  12. MENDOZA YP, Becchetti C, Watt KD, Berzigotti A, et al
    Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases.
    Semin Liver Dis. 2021;41:448-460.
    PubMed     Abstract available


  13. HASHEM A, Khalouf A, Acosta A
    Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review.
    Semin Liver Dis. 2021;41:435-447.
    PubMed     Abstract available


  14. ARRESE M, Arab JP, Barrera F, Kaufmann B, et al
    Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity.
    Semin Liver Dis. 2021;41:421-434.
    PubMed     Abstract available


  15. KOHUT TJ, Gilbert MA, Loomes KM
    Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment.
    Semin Liver Dis. 2021;41:525-537.
    PubMed     Abstract available


  16. LI N, Yamamoto G, Fuji H, Kisseleva T, et al
    Interleukin-17 in Liver Disease Pathogenesis.
    Semin Liver Dis. 2021;41:507-515.
    PubMed     Abstract available


    October 2021
  17. JENG WJ, Liaw YF
    Erratum to: Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis.
    Semin Liver Dis. 2021 Oct 1. doi: 10.1055/s-0041-1737024.
    PubMed    


    September 2021
  18. MARIN JJG, Romero MR, Herraez E, Asensio M, et al
    Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems.
    Semin Liver Dis. 2021 Sep 20. doi: 10.1055/s-0041-1735631.
    PubMed     Abstract available


    August 2021
  19. SHERMAN M
    Assessing Toxicity in Drug Trials in Liver Disease.
    Semin Liver Dis. 2021;41:277-284.
    PubMed     Abstract available


  20. KAWAGUCHI T, Charlton M, Kawaguchi A, Yamamura S, et al
    Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
    Semin Liver Dis. 2021;41:225-234.
    PubMed     Abstract available


  21. ZELBER-SAGI S
    Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations.
    Semin Liver Dis. 2021;41:248-262.
    PubMed     Abstract available


  22. NILLES KM, Levitsky J
    Current and Evolving Indications for Simultaneous Liver Kidney Transplantation.
    Semin Liver Dis. 2021;41:308-320.
    PubMed     Abstract available


  23. MA L, Khatib S, Craig AJ, Wang XW, et al
    Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution.
    Semin Liver Dis. 2021;41:321-330.
    PubMed     Abstract available


  24. MOLLER S, Kimer N, Kronborg T, Grandt J, et al
    Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms.
    Semin Liver Dis. 2021;41:235-247.
    PubMed     Abstract available


  25. ENGELMANN C, Martino VD, Kerbert AJC, Weil-Verhoeven D, et al
    The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2021;41:298-307.
    PubMed     Abstract available


    July 2021
  26. VAZ K, Goodwin T, Kemp W, Roberts S, et al
    Artificial Intelligence in Hepatology: A Narrative Review.
    Semin Liver Dis. 2021 Jul 29. doi: 10.1055/s-0041-1731706.
    PubMed     Abstract available


  27. ZHOU Y, Tao J, Calvisi DF, Chen X, et al
    Role of Lipogenesis Rewiring in Hepatocellular Carcinoma.
    Semin Liver Dis. 2021 Jul 26. doi: 10.1055/s-0041-1731709.
    PubMed     Abstract available


  28. KAHL S, Putzer J, Roden M
    Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis.
    Semin Liver Dis. 2021 Jul 21. doi: 10.1055/s-0041-1732354.
    PubMed     Abstract available


    June 2021
  29. JENG WJ, Liaw YF
    Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis.
    Semin Liver Dis. 2021 Jun 28. doi: 10.1055/s-0041-1729973.
    PubMed     Abstract available


  30. HSU YC, Tseng CH, Huang YT, Yang HI, et al
    Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective.
    Semin Liver Dis. 2021 Jun 23. doi: 10.1055/s-0041-1730924.
    PubMed     Abstract available


  31. BRESSON-HADNI S, Spahr L, Chappuis F
    Hepatic Alveolar Echinococcosis.
    Semin Liver Dis. 2021 Jun 23. doi: 10.1055/s-0041-1730925.
    PubMed     Abstract available


  32. SU YY, Li CC, Lin YJ, Hsu C, et al
    Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives.
    Semin Liver Dis. 2021 Jun 15. doi: 10.1055/s-0041-1730949.
    PubMed     Abstract available


    May 2021
  33. HAEP N, Florentino RM, Squires JE, Bell A, et al
    The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone.
    Semin Liver Dis. 2021 May 15. doi: 10.1055/s-0041-1725023.
    PubMed     Abstract available


  34. USON JUNIOR PLS, Nagalo BM, Ahn DH, Bekaii-Saab T, et al
    Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0040-1722646.
    PubMed     Abstract available


  35. MOECKLI B, Majno P, Orci LA, Peloso A, et al
    Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective.
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0041-1723032.
    PubMed     Abstract available


  36. SEKIBA K, Otsuka M, Koike K
    Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic Liver.
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0041-1723033.
    PubMed     Abstract available


  37. GIL-GOMEZ A, Brescia P, Rescigno M, Romero-Gomez M, et al
    Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers.
    Semin Liver Dis. 2021;41:191-205.
    PubMed     Abstract available


  38. ORTIZ V, Ellenberg SS, Weinberg EM
    Blinding in Clinical Trials for Chronic Liver Diseases.
    Semin Liver Dis. 2021;41:163-171.
    PubMed     Abstract available


  39. DUNN MA, Kappus MR, Bloomer PM, Duarte-Rojo A, et al
    Wearables, Physical Activity, and Exercise Testing in Liver Disease.
    Semin Liver Dis. 2021;41:128-135.
    PubMed     Abstract available


    January 2021
  40. YAO FY, Fidelman N, Mehta N
    The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma.
    Semin Liver Dis. 2021 Jan 14. doi: 10.1055/s-0040-1716565.
    PubMed     Abstract available


  41. ROEDIGER R, Fleckenstein J
    Intrahepatic Cholestasis of Pregnancy: Natural History and Current Management.
    Semin Liver Dis. 2021;41:103-108.
    PubMed     Abstract available


  42. STOTTS MJ, Wentworth BJ, Northup PG
    Management of Portal Vein Thrombosis in Cirrhosis.
    Semin Liver Dis. 2021;41:79-86.
    PubMed     Abstract available


  43. WILKINSON PD, Duncan AW
    Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury.
    Semin Liver Dis. 2021;41:42-49.
    PubMed     Abstract available


  44. ZHANG Y, Solinas A, Cairo S, Evert M, et al
    Molecular Mechanisms of Hepatoblastoma.
    Semin Liver Dis. 2021;41:28-41.
    PubMed     Abstract available


  45. DHANASEKARAN R
    Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches.
    Semin Liver Dis. 2021;41:9-18.
    PubMed     Abstract available


  46. BYRD K, Alqahtani S, Yopp AC, Singal AG, et al
    Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma.
    Semin Liver Dis. 2021;41:1-8.
    PubMed     Abstract available


  47. HARTMANN P, Schnabl B
    New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease.
    Semin Liver Dis. 2021;41:87-102.
    PubMed     Abstract available


  48. FERREIRA-GONZALEZ S, Rodrigo-Torres D, Gadd VL, Forbes SJ, et al
    Cellular Senescence in Liver Disease and Regeneration.
    Semin Liver Dis. 2021;41:50-66.
    PubMed     Abstract available


  49. WANG H, Calvisi DF, Chen X
    Organoids for the Study of Liver Cancer.
    Semin Liver Dis. 2021;41:19-27.
    PubMed     Abstract available


    September 2020
  50. HEIMBACH JK
    Evolution of Liver Transplant Selection Criteria and U.S. Allocation Policy for Patients with Hepatocellular Carcinoma.
    Semin Liver Dis. 2020 Sep 17. doi: 10.1055/s-0040-1709492.
    PubMed     Abstract available


  51. ROWE IA
    Histological Endpoints for Nonalcoholic Steatohepatitis Trials: Lights and Shadows.
    Semin Liver Dis. 2020 Sep 9. doi: 10.1055/s-0040-1709491.
    PubMed     Abstract available


    August 2020
  52. LIZARDO-THIEBAUD MJ, Cervantes-Alvarez E, Limon-de la Rosa N, Tejeda-Dominguez F, et al
    Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Semin Liver Dis. 2020;40:321-330.
    PubMed     Abstract available


    June 2020
  53. MANDORFER M, Hernandez-Gea V, Garcia-Pagan JC, Reiberger T, et al
    Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review.
    Semin Liver Dis. 2020 Jun 18. doi: 10.1055/s-0040-1708806.
    PubMed     Abstract available


  54. KNORR J, Wree A, Tacke F, Feldstein AE, et al
    The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis.
    Semin Liver Dis. 2020 Jun 11. doi: 10.1055/s-0040-1708540.
    PubMed     Abstract available


  55. IBRAHIM SH, Hirsova P, Malhi H, Gores GJ, et al
    Nonalcoholic Steatohepatitis Promoting Kinases.
    Semin Liver Dis. 2020 Jun 11. doi: 10.1055/s-0040-1713115.
    PubMed     Abstract available


  56. FREEBURG SH, Goessling W
    Hepatobiliary Differentiation: Principles from Embryonic Liver Development.
    Semin Liver Dis. 2020 Jun 11. doi: 10.1055/s-0040-1709679.
    PubMed     Abstract available


    May 2020
  57. SUGAHARA G, Ishida Y, Sun J, Tateno C, et al
    Art of Making Artificial Liver: Depicting Human Liver Biology and Diseases in Mice.
    Semin Liver Dis. 2020;40:189-212.
    PubMed     Abstract available


  58. ABERG F, Farkkila M
    Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions.
    Semin Liver Dis. 2020;40:154-162.
    PubMed     Abstract available


  59. DOLIN CE, Arteel GE
    The Matrisome, Inflammation, and Liver Disease.
    Semin Liver Dis. 2020;40:180-188.
    PubMed     Abstract available


  60. JORDAN RI, Tandon P
    Emerging Role of Palliative Care in Patients with Advanced Liver Disease.
    Semin Liver Dis. 2020;40:163-170.
    PubMed     Abstract available


  61. HILSCHER MB, Shah VH
    Neutrophil Extracellular Traps and Liver Disease.
    Semin Liver Dis. 2020;40:171-179.
    PubMed     Abstract available


    April 2020
  62. MATSUDA M, Seki E
    Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.
    Semin Liver Dis. 2020 Apr 2. doi: 10.1055/s-0040-1708876.
    PubMed     Abstract available


    February 2020
  63. KANG N
    Mechanotransduction in Liver Diseases.
    Semin Liver Dis. 2020;40:84-90.
    PubMed     Abstract available


  64. FICKERT P, Rosenkranz AR
    Cholemic Nephropathy Reloaded.
    Semin Liver Dis. 2020;40:91-100.
    PubMed     Abstract available


  65. LLEO A, Leung PSC, Hirschfield GM, Gershwin EM, et al
    The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review.
    Semin Liver Dis. 2020;40:34-48.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: